Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 1
748 Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
748 Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors
Online download statistics by month:
Online download statistics by month: November 2023 to June 2025
Abstract
Full
Pdf
Nov 2023
238
0
19
Dec 2023
72
0
9
Jan 2024
33
0
3
Feb 2024
84
0
8
Mar 2024
146
0
8
Apr 2024
130
0
10
May 2024
86
0
20
Jun 2024
95
0
10
Jul 2024
86
0
6
Aug 2024
122
0
13
Sep 2024
161
0
15
Oct 2024
186
0
12
Nov 2024
178
0
13
Dec 2024
133
0
17
Jan 2025
180
0
14
Feb 2025
75
0
16
Mar 2025
0
0
10
Apr 2025
0
0
9
May 2025
0
0
6
Jun 2025
1
0
6
Total
2006
0
224
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?